ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Comorbidity"

  • Abstract Number: 0124 • ACR Convergence 2022

    Evaluation of Comorbidity Burden and Its Effect on Lung Disease Progression and Mortality in a Cohort of Patients with Interstitial Pneumonia with Autoimmune Features

    Elena Joerns1, Michelle Ghebranious1, Traci Adams1 and Una Makris2, 1UT Southwestern, Dallas, TX, 2UT Southwestern Medical Center and Dallas VA, Dallas, TX

    Background/Purpose: Interstitial pneumonia with autoimmune features (IPAF) is a subset of interstitial lung disease (ILD) which manifests with interstitial pneumonia and features of autoimmunity, yet…
  • Abstract Number: 1390 • ACR Convergence 2022

    Distinct Patterns of Multimorbidity Are Associated with Longitudinal Disease Activity and Functional Status in a Multicenter, Prospective Rheumatoid Arthritis Cohort

    Sarah Dutt1, Punyasha Roul2, Yangyuna Yang3, Kaleb Michaud3, Brian Sauer4, Grant Cannon5, Joshua Baker6, Jeffrey Curtis7, Ted Mikuls8 and Bryant England3, 1University of Nebraska Medical Center, Omaha, 2UNMC, Omaha, NE, 3University of Nebraska Medical Center, Omaha, NE, 4Salt Lake City VA/University of Utah, Salt Lake City, UT, 5Salt Lake City VA, Salt Lake city, 6University of Pennsylvania and Corporal Michael J. Crescenz VA Medical Center, Philadelphia, 7Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 8Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Rheumatoid arthritis (RA) predisposes to the development of other chronic conditions such as osteoporosis, cardiovascular disease, and lung disease. Previously, we used unsupervised machine…
  • Abstract Number: 1953 • ACR Convergence 2022

    Mortality in Rheumatoid Arthritis: Changing Causes and Predictive Factors. Study of a Cohort Followed Prospectively

    Cristina Corrales1, Fabricio Benavides Villanueva1, Ivan Ferraz Amaro2, Nuria Vegas Revenga3, Virgi Portilla4, Ricardo Blanco5, Miguel Ángel González-Gay6 and Alfonso Corrales4, 1Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Division of Rheumatology. Hospital Universitario de Canarias. Spain., Santa Cruz de Tenerife, Spain, 3Hospital Galdakao- Usansolo, Galdakao, Spain, 4Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL; and Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 5Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 6Department of Medicine and Psychiatry, Universidad de Cantabria; Rheumatology Division, Hospital Universitario Marqués de Valdecilla; Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic diseases of the musculoskeletal system, IDIVAL, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Background/Purpose: Patients with Rheumatoid Arthritis (RA) present an increased risk of mortality. In the last decades, mortality rates tended to decrease but cardiovascular (CV) events…
  • Abstract Number: 0189 • ACR Convergence 2022

    Characteristics Associated with a Positive PEST Screening Among Patients with Psoriasis Without a Diagnosis of Psoriatic Arthritis: Results from the Global Psoriasis and Beyond Study

    Alexis Ogdie1, April Armstrong2, Barbra Bohannan3, Sicily Mburu4, Laura Coates5, Elena Kornyeyeva6, Susan Frade6, Silvia Fernandez Barrio7 and Matthias Augustin8, 1Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2Keck School of Medicine of USC, Dermatology, Los Angeles, CA, 3Psoriasisförbundet, Stockholm, Sweden, 4IFPA, Stockholm, Sweden, 5Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK, Oxford, England, United Kingdom, 6Novartis Pharma AG, Basel, Switzerland, 7Asociación Para El Enfermo De Psoriasis, Buenos Aires, Argentina, 8University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    Background/Purpose: Psoriatic arthritis (PsA) is a common clinical feature in patients (pts) with psoriasis (PsO); up to one third of PsO pts will develop PsA…
  • Abstract Number: 1408 • ACR Convergence 2022

    In RA Patients Without Prevalent CVD, Incident CVD Is Only Associated with Traditional Risk Factors: A 20-year Follow up in the CARRÉ Cohort Study

    Reinder Raadsen1, Rabia Agca2, Maarten Boers3, Vokko van Halm2, Mike Peters4, Yvo Smulders2, Joline Beulens2, Marieke Blom2, Coen Stehouwer5, Alexandre Voskuyl2, Willem Lems6 and Michael Nurmohamed7, 1Reade Rheumatology Center, Amsterdam, Netherlands, 2Amsterdam UMC, Amsterdam, Netherlands, 3Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands, 4Amsterdam UMC; UMC Utrecht, Amsterdam, Netherlands, 5MUmc, Amsterdam, Netherlands, 6Amsterdam University Medical Centers, Amsterdam, Netherlands, 7Amsterdam University Medical Center, Kortenhoef, Netherlands

    Background/Purpose: We have documented that patients with rheumatoid arthritis (RA) are at increased risk to develop cardiovascular disease (CVD) compared to the general population, even…
  • Abstract Number: 1964 • ACR Convergence 2022

    Systematic Screening of Multimorbidities Results in an Increased Intake of Comorbidity Preventive Medications and a Decreased Hospitalization Rate

    Claire DAIEN1, Vera Georgescu2, Guillaume Decarriere3, Jenica Pastor3, Gaël Mouterde4, Cédric Lukas5, Grégoire Mercier3 and Jacques Morel6, 1University Hospital, Saint-Gély-du-Fesc, France, 2Unité de Recherche Médico-économique, CHU de Montpellier et Université de Montpellier, Montpellier, France, 3CHU Montpellier, Montpellier, France, 4Lapeyronie Hospital, Montpellier, France, 5University Hospital Centre Montpellier, University of Montpellier, Montpellier, France, 6University and CHU Montpellier, Montpellier, France

    Background/Purpose: A systematic screening of multimorbidities is performed since 2014 at the Montpellier University Hospital in patients with chronic inflammatory rheumatic diseases (IRD). The objective…
  • Abstract Number: 0246 • ACR Convergence 2022

    Comorbidity Clusters in Patients with Rheumatoid Arthritis Predict Survival Prognosis

    Cynthia Crowson1, Tina Gunderson2, John Davis2, Elena Myasoedova2, Vanessa Kronzer2, Caitrin Coffey2, Bradly Kimbrough3 and Elizabeth Atkinson2, 1Mayo Clinic, Eyota, MN, 2Mayo Clinic, Rochester, MN, 3Mayo Clinic Rochester, Rochester, MN

    Background/Purpose: Comorbidities are common in patients with rheumatoid arthritis (RA), but there is little information regarding the occurrence of distinct comorbidity patterns in patients with…
  • Abstract Number: 1506 • ACR Convergence 2022

    Multimorbidity in Psoriasis as a Risk Factor for Psoriatic Arthritis: A Population-Based Study

    Paras Karmacharya1, Rikesh Chakradhar2, Alexis Ogdie3, John Davis4, Tina Gunderson4, Cassondra Hulshizer4, Kerry Wright4, Megha M. Tollefson5, Ali Duarte-Garcia4, Delamo Bekele4, Hilal Maradit Kremers4, Floranne Ernste4 and Cynthia Crowson6, 1Vanderbilt University, Nashville, TN, 2St. Christopher's Hospital, Philadelphia, 3Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 4Mayo Clinic, Rochester, MN, 5Mayo Clinic, Rochester, 6Mayo Clinic, Eyota, MN

    Background/Purpose: Psoriasis is a systemic inflammatory disorder associated with cardiometabolic and other comorbidities. Psoriasis frequently precedes development of psoriatic arthritis (PsA), and comorbidities in psoriasis…
  • Abstract Number: 1987 • ACR Convergence 2022

    Prednisone Use and the Incidence of Hyperglycemia or Diabetes in Patients with Rheumatoid Arthritis; A 10-year Sub Analysis of the BeSt Study

    CF Allaart1, Sytske Anne Bergstra2, Tom Huizinga1 and Joy van der Pol3, 1Leiden University Medical Center, Leiden, Netherlands, 2LUMC, Leiden, Netherlands, 3Leiden University Medical Center, Utrecht, Netherlands

    Background/Purpose: Use of prednisone in rheumatoid arthritis has been questioned because it may trigger side effects such as hyperglycemia and diabetes. However, disease activity (DAS)…
  • Abstract Number: 0255 • ACR Convergence 2022

    Is Abatacept as Effective and Safe in Rheumatoid Arthritis Patients with Previous Malignancy as in Those Without?

    Yosuke Kunishita1, Kayo Harita2, Chikara Honda2, Masaki Mitsuhasi2 and Shouhei Nagaoka2, 1Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan, 2Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan

    Background/Purpose: In 2019, a study based on post-marketing surveillance data in Japan reported that abatacept (ABT) was as effective and safe in elderly patients with…
  • Abstract Number: 1605 • ACR Convergence 2022

    Profound Anticoagulant Effects of Initial Antirheumatic Treatments in Early Rheumatoid Arthritis Patients; A NORD-STAR Spin-off Study

    Bas Dijkshoorn1, Daisy Vedder1, Anna Rudin2, Dan Nordstrom3, Bjorn Gudbjornsson4, Kristina Lend5, Till Uhlig6, Espen Haavardsholm6, Gerdur Maria Grondal7, Merete L Hetland8, Marte Heiberg6, Mikkel Østergaard9, Kim Horslev-Petersen10, Jon Lampa11, Ronald van Vollenhoven12, Aleksandra antovic13 and Michael Nurmohamed14, 1Reade Rheumatology Center, Amsterdam, Netherlands, 2Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy of University of Gothenburg, Gothenburg, Sweden, 3Helsinki University Hospital, Helsinki, Finland, 4Centre for Rheumatology Research, University Hospital, Reykjavik, Iceland, 5The Karolinska Institute, Stockholm, Sweden, 6Diakonhjemmet Hospital, Oslo, Norway, 7Landspitali University Hospital, Centre for Rheumatology Research, Reykjavik, Iceland, 8Rigshospitalet, Glostrup, Denmark, 9Rigshospitalet, University of Copenhagen, Glostrup, Denmark, 10Danish Hospital for Rheumatic Diseases, Haderslev, Denmark, 11Department of Medicine, Rheumatology Unit, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden, 12Amsterdam University Medical Centers, Amsterdam, Netherlands, 13Karolinska Institute, Department of Medicine Solna, Division of Rheumatology, Stockholm, Sweden, 14Amsterdam University Medical Center, Kortenhoef, Netherlands

    Background/Purpose: Patients with rheumatoid arthritis (RA) are at an increased risk of venous thromboembolism. Thus far, there have not been any comparative studies investigating the…
  • Abstract Number: 2001 • ACR Convergence 2022

    Cardiovascular Risk Factors and Therapeutic Outcome in Rheumatoid Arthritis – Real World Data

    Tanya Shivacheva, Medical University prof.dr. P. Stoyanov, Varna, Bulgaria, Varna, Bulgaria

    Background/Purpose: Sustained targeted therapeutic outcome with biological therapy in real clinical conditions is not yet achievable in a large proportion of rheumatoid arthritis (RA) patients.…
  • Abstract Number: 0259 • ACR Convergence 2022

    Impact of Comorbidity on Disease Activity and Functional Status in Patients with Rheumatoid Arthritis Receiving Biologic DMARDs, a Longitudinal Analysis of the KOBIO-RA

    Ju Yeon Kim1, Kichul Shin2, Eun Bong Lee1 and Jun Won Park1, 1Seoul National University Hospital, Seoul, Republic of Korea, 2Seoul Metropolitan Government- Seoul National University Boramae Medical Center, Seoul, Republic of Korea

    Background/Purpose: This study aims to evaluate the impact of comorbidities on disease activity and functional disability in patients with RA treated with biological disease-modifying anti-rheumatic…
  • Abstract Number: 1609 • ACR Convergence 2022

    Comorbidity Clusters in Ankylosing Spondylitis and Their Association with Disease Activity and Functional Impairment: Data from the PSOAS Cohort

    Paras Karmacharya1, Cynthia Crowson2, Ryan Lennon3, Dilli Poudel4, John Davis3, Alexis Ogdie5, Jean Liew6, Michael Ward7, Mariko Ishimori8, Michael Weisman9, Matthew Brown10, Mohammad Rahbar11, Mark Hwang12, John Reveille13 and Lianne Gensler14, 1Vanderbilt University, Nashville, TN, 2Mayo Clinic, Eyota, MN, 3Mayo Clinic, Rochester, MN, 4Indiana Regional Medical Center, Indiana, PA, 5Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, 6Boston University, Boston, MA, 7National Institutes of Health, Rockville, MD, 8Cedars-Sinai Health System, Los Angeles, CA, 9Adjunct Professor of Medicine, Stanford University; Distinguished Professor of Medicine Emeritus, David Geffen School of Medicine at UCLA, Los Angeles, CA, 10Genomics England, London, United Kingdom, 11University of Texas Health Science Center at Houston, Houston, TX, 12McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, 13University of Texas McGovern Medical School, Houston, TX, 14Department of Medicine, Division of Rheumatology, University of California San Francisco, San Francisco, CA

    Background/Purpose: Comorbidities occur more frequently in patients with ankylosing spondylitis (AS) than in the general population and are associated with higher morbidity and mortality. Some…
  • Abstract Number: 2009 • ACR Convergence 2022

    Long-term Outcome of a Treat-to-target Strategy in Elderly-onset Rheumatoid Arthritis with Chronic Lung Diseases

    Manami Nomura1, Takahiko Sugihara2, Hiroyuki Baba1, Tatsuro Ishizaki3, Tadashi Hosoya1, Mari Kamiya1, Takumi Matsumoto2, Kanae Kubo4, Fumio Hirano5, Masayo Kojima6, Nobuyuki Miyasaka5, Shinsuke Yasuda5 and Masayoshi Harigai7, 1Tokyo Medical and Dental University (TMDU), Tokyo, Japan, 2Department of Medicine and Rheumatology, Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 3Human Care Research Team, Tokyo Metropolitan Institute of Gerontology., Tokyo, Japan, 4Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan, 5Department of Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan, 6Department of Frailty Research, Center for Gerontology and Social Science, National Center for Geriatrics and Gerontology, Nagoya, Japan, 7Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan

    Background/Purpose: Elderly patients with rheumatoid arthritis (RA) tend to have a higher risk for drug-related adverse events (AEs) than younger patients, and the effectiveness and…
  • 1
  • 2
  • 3
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences